Strategic question
This global Insurer looked to accelerate its Digital Health footprint in Asia, prioritise markets for innovation, and scout for HealthTech ventures that met specific Therapeutic and Category objectives
How Galen Growth helped
From market signal to decision-ready evidence
Galen Growth combined HealthTech Alpha intelligence with structured ecosystem mapping and competitive intelligence and due diligence to assess the relevant markets, ventures, and evidence against the client's decision criteria.
Outcomes
After identifying cardio, oncology and diabetes, as the top health concerns in the four markets, we then delivered a Scouting mission that determined exact HealthTech start ups capable of delivering on the insurer’s strategic objectives around scale and frequency of use
Key results
Our approach
A repeatable path to a defensible decision
Define
Clarify the strategic question, decision owner, market boundaries, and success criteria.
Map
Identify the relevant ventures, markets, competitors, partnerships, and evidence signals.
Assess
Evaluate maturity, traction, clinical relevance, commercial fit, and operational readiness.
Decide
Translate the evidence into a shortlist, benchmark, market view, or portfolio recommendation.
Related work
More digital health case studies
Sourcing OMICS Ventures to Shape Oncology and Wellness Strategy
Which OMICS-led ventures tackling oncology and wellness are mature enough to partner with an enterprise insurer?
Sourcing HealthTech Ventures to Power Non-Fluid Underwriting
Which ventures across digital biomarkers, DTx, genomics and teleconsultation are mature enough to enable non-fluid underwriting?
Pressure-Testing a Digital Health Partnership Before Commitment
How does our preferred venture partner compare against credible alternatives in the same market and therapeutic focus?
